微流体技术和模拟模型用于研究怀孕期间的药理动力学
Ananth K Kammala1, Lauren S Richardson1, Enkhtuya Radnaa1
1Division of Basic Science and Translational Research, Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX, United States.
新的器官芯片和in silico模型准确地预测了怀孕期间的药物转移,为孕妇提供了比动物试验更安全的替代方案.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物医学工程 生物医学工程
- 生殖健康 生殖健康
背景情况:
- 早产和孕产妇/新生儿死亡率需要在怀孕期间进行更好的药物检测.
- 目前的模型 (2D/3D细胞,动物) 缺乏临床翻译性,将孕妇排除在药物开发之外.
- In silico和器官芯片平台为怀孕期间评估治疗剂提供了新的解决方案.
研究的目的:
- 评估在怀孕期间用于药物药理动学的in silico模拟和微流体器官芯片平台的实用性.
- 将这些新平台的药物转移数据与传统动物模型进行比较.
- 评估这些模型在改善孕妇药物开发方面的潜力.
主要方法:
- 开发了7种细胞类型的多器官胎儿-母体芯片接口 (FMi-PLA-OOC),用于研究药物药理动力学.
- 通过FMi-PLA-OOC测试了普拉瓦斯塔丁的转移,并将其与体内动物和体外胎盘 perfusion 数据进行了比较.
- 利用模拟软件 (Gastroplus®) 来从非孕妇数据中预测孕妇药理动力学.
主要成果:
- 在FMi-PLA-OOC和in silico模型中,普拉瓦斯塔丁的转移率约为18%.
- 动物模型显示药物积累显著更高 (大约1. 33%) 在羊水中.
- 新型平台展示了类似的和可能更可翻译的药理动力学预测.
结论:
- 芯片上的胎儿-母亲接口 (FMi-PLA-OOC) 和in silico模型是研究妊娠药物药理动学的可行替代方案.
- 这些平台为胎盘药物运输和新陈代谢提供了宝贵的见解.
- 该研究提供了一条减少"治疗孤儿"的途径,并通过加强孕妇人群的药物开发来改善孕妇/新生儿健康结果.
更多相关视频
08:06A Microfluidics Approach for the Functional Investigation of Signaling Oscillations Governing Somitogenesis
Published on: March 19, 2021
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
